Your shopping cart is currently empty

mPEG-Amide-tri(DPCA) is a PEG-DPCA conjugate that can self-assemble with PEG-DPCA conjugate 1 to form a supramolecular polymer hydrogel with a nanofiber structure. This hydrogel exhibits shear-thinning properties, making it suitable for injectable drug delivery. It possesses a high drug-loading capacity and can biodegrade in vivo into DPCA and PEG, facilitating ear hole regeneration in adult non-healing mice. mPEG-Amide-tri(DPCA) is applicable in tissue regeneration research.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | mPEG-Amide-tri(DPCA) is a PEG-DPCA conjugate that can self-assemble with PEG-DPCA conjugate 1 to form a supramolecular polymer hydrogel with a nanofiber structure. This hydrogel exhibits shear-thinning properties, making it suitable for injectable drug delivery. It possesses a high drug-loading capacity and can biodegrade in vivo into DPCA and PEG, facilitating ear hole regeneration in adult non-healing mice. mPEG-Amide-tri(DPCA) is applicable in tissue regeneration research. |
| Cas No. | 2459303-76-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.